ARCHIVES

PROPOC Study Analyses Six Cancer DRGs

This article is from The Cancer Letter archive.

Vol. 12 No. 03 | January 17, 1986

Download PDF Visit The Full Archive

Related Articles

It’s Official – UCLA Recognize As 19th Comprehensive Center

January 7, 1977

Montana Drug Salesman Pleads Guilty to Selling Counterfeit Avastin

July 25, 2013

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992

NCI Denies GAO Report That Backlog Still Exists, Says Most were Published As Research Results

May 18, 1979

Gemcitabine Improves DFS In Resected Pancreatic Cancer

June 24, 2005

Onward to 2010? NCI promises faster progress for more money.

May 20, 2005